Publications by authors named "A Belluzzi"
Biliopancreatic diversion with duodenal switch (BPD-DS) and single anastomosis duodeno-ileostomy with sleeve (SADI-S) are associated with superior and sustained weight loss outcomes. Despite their growing popularity, long-term safety profiles, particularly the risk of internal hernia (IH), remain underexplored. This study aimed to evaluate the incidence and characteristics of IH following BPD-DS and SADI-S procedures, comparing their clinical presentation, diagnostic methods, and outcomes.
View Article and Find Full Text PDFArticle Synopsis
- The global rise in obesity has led to the need for clear guidelines combining medical, endoscopic, and surgical methods for effective treatment.
- An expert panel formed by IFSO-EC created evidence-based recommendations for treating adults with a BMI of 30 or higher, focusing on integrating lifestyle interventions and various weight loss techniques.
- These guidelines emphasize a comprehensive approach to obesity management, recognizing it as a complex, chronic disease that requires understanding all therapeutic options available.
Article Synopsis
- Metabolic and bariatric surgery (MBS) is the top treatment for obesity, with laparoscopic sleeve gastrectomy (SG) being the most popular due to its ease and positive short-term results.* -
- Despite these benefits, SG can lead to rare but serious complications such as splenic injuries, esophageal perforation, and other issues that surgeons may not be familiar with.* -
- This review highlights the importance of recognizing and managing these rare complications after SG, emphasizing the need for education and resources for healthcare professionals.*
Background: Obesity and its related medical conditions are well-established contributors to the development of chronic kidney disease (CKD). Metabolic and bariatric surgery (MBS), including procedures such as sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB), is a potential intervention for these individuals. However, the heightened risk of postoperative complications casts doubts on the suitability of MBS in this population.
View Article and Find Full Text PDFBackground: The obesity epidemic has led to an increase in the proportion of patients with chronic liver disease due to metabolic associated steatosic liver disease and in the prevalence of obesity in patients with cirrhosis. Metabolic and bariatric surgery (MBS) has been proven to determine weight loss, obesity-related medical problems remission, and liver steatosis, inflammation, and fibrosis improvement. However, cirrhosis and portal hypertension are well-known risk factors for increased morbidity and mortality after surgery.
View Article and Find Full Text PDF